Results: 58

Immunological-based approaches for cancer therapy

Clinics; 73 (supl.1), 2018
The immunologic landscape of tumors has been continuously unveiled, providing a new look at the interactions between cancer cells and the immune system. Emerging tumor cells are constantly eliminated by the immune system, but some cells establish a long-term equilibrium phase leading to tumor immunoediti...

Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer

Clinics; 73 (supl.1), 2018
While cancer immunotherapy has gained much deserved attention in recent years, many areas regarding the optimization of such modalities remain unexplored, including the development of novel approaches and the strategic combination of therapies that target multiple aspects of the cancer-immunity cycle. Ou...

Improving adenoviral vectors and strategies for prostate cancer gene therapy

Clinics; 73 (supl.1), 2018
Gene therapy has been evaluated for the treatment of prostate cancer and includes the application of adenoviral vectors encoding a suicide gene or oncolytic adenoviruses that may be armed with a functional transgene. In parallel, versions of adenoviral vector expressing the p53 gene (Ad-p53) have been te...

Preparation and characterization of non-viral gene delivery systems with pEGFP-C1 Plasmid DNA

ABSTRACT In recent years, non-viral delivery systems for plasmid DNA have become particularly important. They can overcome the disadvantages of viral systems such as insertional mutagenesis and unpredicted immunogenicity. Some additional advantages of non-viral gene delivery systems are; good stability, ...

Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its' effectiveness with botulinum toxin injection

Int. braz. j. urol; 43 (6), 2017
ABSTRACT Objectives: To compare the effects and histopathological changes of botulinum neurotoxin type A and lysozyme gene injections into prostate tissue within a testosterone induced benign prostate hyperplasia rat model. Materials and Methods: 40 male Wistar rats were randomized into four Groups. Gr...

El impacto ético de las nuevas tecnologías de edición genética

Rev. bioét. (Impr.); 25 (3), 2017
Resumen El descubrimiento de la técnica CRISPR/CAS 9 de edición genética abre importantes horizontes para la investigación científica. Los problemas éticos, jurídicos y sociales que pueden importar su aplicación a humanos son inmensos, lo que justifica un amplio debate social. El trabajo indaga s...

CRISPR/Cas9 y la terapia génica
CRISPR/Cas9 and gene therapy

Medicina (B.Aires); 77 (5), 2017
El desarrollo de técnicas que permitan editar o corregir con precisión y eficiencia el genoma de células vivas es uno de los objetivos principales de la investigación biomédica. En las últimas décadas se han investigado e implementado distintas herramientas de edición genómica entre las cuales s...

Gene therapy: advances, challenges and perspectives

Einstein (Säo Paulo); 15 (3), 2017
ABSTRACT The ability to make site-specific modifications to the human genome has been an objective in medicine since the recognition of the gene as the basic unit of heredity. Thus, gene therapy is understood as the ability of genetic improvement through the correction of altered (mutated) genes or site-...

Immunotherapy and gene therapy as novel treatments for cancer

Colomb. med; 48 (3), 2017
Abstract The immune system interacts closely with tumors during the disease development and progression to metastasis. The complex communication between the immune system and the tumor cells can prevent or promote tumor growth. New therapeutic approaches harnessing protective immunological mechanisms hav...